Hypertension Treatment in Nigeria (HTN) Program: rationale and design for a type 2 hybrid, effectiveness, and implementation interrupted time series trial

Abstract Background Hypertension is the most common cardiovascular disease in Nigeria and contributes to a large non-communicable disease burden. Our aim was to implement and evaluate a large-scale hypertension treatment and control program, adapted from the Kaiser Permanent Northern California and...

Full description

Bibliographic Details
Main Authors: Abigail S. Baldridge, Kasarachi Aluka-Omitiran, Ikechukwu A. Orji, Gabriel L. Shedul, Tunde M. Ojo, Helen Eze, Grace Shedul, Eugenia N. Ugwuneji, Nonye B. Egenti, Rosemary C. B. Okoli, Boni M. Ale, Ada Nwankwo, Samuel Osagie, Jiancheng Ye, Aashima Chopra, Olutobi A. Sanuade, Priya Tripathi, Namratha R. Kandula, Lisa R. Hirschhorn, Mark D. Huffman, Dike B. Ojji
Format: Article
Language:English
Published: BMC 2022-08-01
Series:Implementation Science Communications
Subjects:
Online Access:https://doi.org/10.1186/s43058-022-00328-9